Psychiatrists' attitudes regarding genetic testing and patient safeguards: A preliminary study

Genetic Testing

Volumn 12, Issue 2, 2008, Pages 245-252

  Hoop, Jinger G ^a   Roberts, Laura Weiss ^a   Green Hammond, Katherine A ^b   Cox, Nancy J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b University of Chicago ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERTIZING; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; INFORMED CONSENT; LAW; LEGAL ASPECT; MALE; MARKETING; MEDICAL ETHICS; MENTAL DISEASE; MENTAL PATIENT; PATIENT COUNSELING; PATIENT SAFETY; PHARMACOGENETICS; PHYSICIAN ATTITUDE; PROBABILITY SAMPLE; PROFESSIONAL SECRECY; PSYCHIATRIST; PSYCHIATRY; UNITED STATES;

ATTITUDE OF HEALTH PERSONNEL; CONFIDENTIALITY; ETHICS, MEDICAL; GENETIC PRIVACY; GENETIC SCREENING; HUMANS; INFORMED CONSENT; MEDICAL RECORDS; PHYSICIANS; PSYCHIATRY; QUESTIONNAIRES;

EID: 45549103890     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2007.0097     Document Type: Article

References (39)

1. Appelbaum PS (2004) Ethical issues in psychiatric genetics. J Psychiatr Pract 10:343-351.
2. Appelbaum PS, Grisso T (1995) The MacArthur treatment competence study. I: mental illness and competence to consent to treatment. Law Hum Behav 19:105-126.
3. Biesecker BB, Peay HL (2003) Ethical issues in psychiatric genetics research: points to consider. Psychopharmacology 171:27-35.
4. Campbell E, Ross LF (2004) Attitudes of healthcare professionals and parents regarding genetic testing for violent traits in childhood. J Med Ethics 30:580-586.
5. Campbell E, Ross LF (2005) Parental attitudes and beliefs regarding the genetic testing of children. Community Genet 8:94-102.
6. Centers for Disease Control (2006) Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 55(RR14):1-17.
7. Centers for Disease Control and Prevention (2004) Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing - Atlanta, Denver, Raleigh-Durham, and Seattle, 2003. MMWR Morb Mortal Wkly Rep 53:603-606.
8. Chase GA, Geller G, Havstad SL, Holtzman NA, Bassett SS (2002) Physicians' propensity to offer genetic testing for Alzheimer's disease: results from a survey. Genet Med 4:297-303.
9. Clayton EW (2003) Ethical, legal, and social implications of genomic medicine. N Engl J Med 349:562-569.
10. de Leon J, Armstrong SC, Cozza KL (2006) Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19. Psychosomatics 47:75-85.
11. DeLisi LE, Bertisch H (2005) A preliminary comparison of the hopes of researchers, clinicians, and families for the future ethical use of genetic findings in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 141B:110-115.
12. Detera-Wadleigh SD, McMahon FJ (2006) G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biol Psychiatry 60:106-114.
13. Dinwiddie S, Hoop JG, Gershon E (2004) Ethical issues in the use of genetic information. Int Rev Psychiatry 16:320-328.
14. Farmer A, Owen MJ (1996) Genomics: the next psychiatric revolution? Br J Psychiatry 169:135-138.
15. Farmer AE, Owen MJ, McGuffin P (2000) Bioethics and genetic research in psychiatry. Br J Psychiatry 176:105-108.
16. Finn CT, Wilcox MA, Kof BR, Blacker D, Racete SR, Sklar P, Smoller JW (2005) Psychiatric genetics: a survey of psychiatrists' knowledge, opinions, and practice patterns. J Clin Psychiatry 66:821-830.
17. Genetic Information Nondiscrimination Act of 2007. Available at http://www.genome.gov=24519851. Accessed June 15, 2005.
18. Gershon ES (2002) The challenges of genetic tests for human behavior. Isr J Psychiatry Relat Sci 39:206-216.
19. Hoop JG, Cook EH Jr., Dinwiddie S, Gershon E (2006) Neurogenetics, behavior, and neurodegenerative disorders. In: Sharpe N, Carter R (eds) Genetic Testing: Care, Consent, and Liability. Wiley, New York, pp 223-237.
20. Jones I, Scourfield J, McCandless F, Craddock N (2002) Attitudes towards future testing for bipolar disorder susceptibility genes: a preliminary investigation. J Affect Disord 71:189-193.
21. Lasky-Su JA, Faraone SV, Glatt SJ, Tsuang MT (2005) Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. Am J Med Genet B Neuropsychiatr Genet 133:110-115.
22. Li D, Collier DA, He L (2006) Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet 15:1995-2002.
23. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177-182.
24. McGuffin P, Southwick L (2003) Fifty years of the double helix and its impact on psychiatry. Aust N Z J Psychiatry 37:657-661.
25. Meiser B, Mitchell PB, McGirr H, van Herten M, Schofield PR (2005) Implications of genetic risk information in families with a high density of bipolar disorder: an exploratory study. Soc Sci Med 60:109-118.
26. Milner KK, Han T, Petty EM (1999) Support for the availability of prenatal testing for neurological and psychiatric conditions in the psychiatric community. Genet Test 3:279-286.
27. Munafo MR, Thiselton DL, Clark TG, Flint J (2006) Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol Psychiatry 11:539-546.
28. Murray TH (1997) Genetic exceptionalism and "future diaries": is genetic information different from other medical information? In: Rothstein MA (ed) Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic era. Yale University Press, New Haven, CT, pp 60-73.
29. Nuffield Council on Bioethics (1998) Mental Disorders and Genetics: The Ethical Context. Nuffield Council on Bioethics, London.
30. Post SG (1996) On not jumping the gun: ethical aspects of APOE gene testing for Alzheimer's disease. Ann NY Acad Sci 802:111-119.
31. Post SG, Whitehouse PJ, Binstock RH, Bird TD, Eckert SK, Farrer LA, Fleck LM, Gaines AD, Juengst ET, Karlinsky H, Miles S, Murray TH, Quaid KA, Relkin NR, Roses AD, St George-Hyslop PH, Sachs GA, Steinbock B, Truschke EF, Zinn AB (1997) The clinical introduction of genetic testing for Alzheimer disease: an ethical perspective. JAMA 277:832-836.
32. Prathikanti S, Weinberger DR (2005) Psychiatric genetics - the new era: genetic research and some clinical implications. Br Med Bull 73-74:107-122.
33. Ross LF (2004) Should children and adolescents undergo genetic testing? Pediatr Ann 33:762-769.
34. Rutter M (2002) Nature, nurture, and development: from evangelism through science toward public policy. Child Dev 73:1-21.
35. Smith LB, Sapers B, Reus VI, Freimer NB (1996) Attitudes towards bipolar disorder and predictive genetic testing among patients and providers. J Med Genet 33:544-549.
36. Trippitelli CL, Jamison KR, Folstein MF, Bartko JJ, DePaulo JR (1998) Pilot study on patients' and spouses' attitudes toward potential genetic testing for bipolar disorder. Am J Psychiatry 155:899-904.
37. United States Department of Health and Human Services Substance Abuse and Mental Health Services Administration (1999) Mental Health: A Report of the Surgeon General. National Academies Press, Rockville, MD.
38. Verma R, Corley DA (2003) How should we select health professionals for studies? Outcomes Manag 7:129-133.
39. World Federation of Neurology Research Group on Huntington's Disease (1990) Ethical issues policy statement on Huntington's disease molecular genetics predictive test. J Med Genet 27:34-38.